Ticker Scorecard - BIIB Basics Company: Biogen Inc. IPO Date: January 3, 1994 Sector: Healthcare Industry: Biotech Market Cap: $21.72B Activated in VL: True Average Daily Range Avg Daily Range: $2.48 | 1.32% Avg Daily Range (30 D): $1.89 | 1.25% Avg Daily Range (90 D): $1.92 | 1.13% Institutional Daily Volume Avg Daily Volume: 2.1M Avg Daily Volume (30 D): 1.02M Avg Daily Volume (90 D): 1.08M Trade Size Avg Trade Size (Sh.): 111 Avg Trade Size (Sh.) (30 D): 39 Avg Trade Size (Sh.) (90 D): 41 Institutional Trades Total Inst.Trades: 43,661 Avg Inst. Trade: $5.91M Avg Inst. Trade (30 D): $16.51M Avg Inst. Trade (90 D): $16.25M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 8 Market Closing Trades Avg Closing Trade: $27.54M Avg Closing Trade (30 D): $47.48M Avg Closing Trade (90 D): $41.14M Avg Closing Volume: 129.69K     News Jan 14, 2025 @ 2:04 PM FDA To Review Under the Skin Weekly Autoinjector F... Source: Vandana Singh Jan 13, 2025 @ 7:06 PM Biogen Bid For Sage Therapeutics Could Strengthen ... Source: Vandana Singh Jan 11, 2025 @ 10:01 AM Stock Market Roundup 2024: Here's What Worked, Wha... Source: The Motley Fool Jan 9, 2025 @ 3:48 PM Alzheimer's Disease Diagnostics Research Report 20... Source: Globe Newswire Jan 4, 2025 @ 12:45 PM These Were the 5 Worst-Performing Stocks in the Na... Source: Eric Volkman Financials   TTM Q3 2024 Q2 2024 Basic EPS $11.1 $2.67 $4.01 Diluted EPS $11.06 $2.66 $4 Revenue $ 9.61B $ 2.47B $ 2.46B Gross Profit $ 7.26B $ 1.83B $ 1.92B Net Income / Loss $ 1.61B $ 388.5M $ 583.6M Operating Income / Loss $ 1.91B $ 451M $ 698.7M Cost of Revenue $ 2.35B $ 638.7M $ 546M Net Cash Flow $ -588.7M $ -209.7M $ 834.5M PE Ratio 12.70     Splits Jan 18, 2001:   1:3